Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-563-2366
Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Radiation Oncology, 2005 - 2009
Loma Linda University Health Education ConsortiumInternship, Internal Medicine, 2004 - 2005
University of California, Irvine, School of MedicineClass of 2004
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
CA State Medical License 2006 - 2025
GA State Medical License 2023 - 2025
American Board of Radiology Radiation Oncology- Join now to see all
Clinical Trials
- Trimodality Management of T1b Esophageal Cancers Start of enrollment: 2010 Oct 01
- A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer Start of enrollment: 2013 Feb 01
- Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2013 Oct 28
- Join now to see all
Publications & Presentations
PubMed
- Defining the Optimal Radiation-induced Lymphopenia Metric to Discern Its Survival Impact in Esophageal Cancer.Pim J J Damen, Max Peters, Brian Hobbs, Yiqing Chen, Uwe Titt
International Journal of Radiation Oncology, Biology, Physics. 2025-05-01 - Impacts of Radiation on Metabolism and Vascular Cell Senescence.Junichi Abe, Khanh Chau, Anahita Mojiri, Guangyu Wang, Masayoshi Oikawa
Antioxidants & Redox Signaling. 2025-04-16 - Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance.Guang Lei, Mingchuang Sun, Jun Cheng, Rui Ye, Zhengze Lu
Cancer Cell. 2025-04-07
Journal Articles
- Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveill...Hong Yang, Steven H Lin, Annals of Surgical Oncology
- Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?☆Zhongxing Liao, Saumil J Gandhi, Steven H Lin, ScienceDirect
Press Mentions
MD Anderson Research Highlights for April 17, 2025April 17th, 2025- Nanobiotix Announces First Data from the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients with Locally Advanced NSCLCMarch 27th, 2025
- New Therapy Shows Promise in Strengthening CAR-T ResponsesFebruary 25th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
